| Financial Year |
March 31 2023 |
| Monetary Funds |
768,503,668.78 |
| Held-for-trading Financial Assets |
50,000,000.00 |
| Notes Receivable |
109,720,383.52 |
| Accounts Receivable |
2,245,410,096.14 |
| Advances to Suppliers |
437,196,634.46 |
| Other Receivables |
107,022,508.55 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,018,804,894.29 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
116,380,912.49 |
| Total Current Assets |
5,179,893,345.86 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
810,000.00 |
| Long-term Equity Investment |
1,381,818,634.12 |
| Investment Properties |
-- |
| Fixed Assetes |
442,900,034.19 |
| Under-construction Projects |
887,926,619.88 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
265,233,342.31 |
| R&D expenses |
5,126,872.66 |
| Goodwill |
2,661,532,584.30 |
| Long-Term Deferred and Prepaid Expenses |
9,109,669.17 |
| Deferred Income Tax Assets |
175,284,719.66 |
| Other Non-Current Assets |
24,241,473.50 |
| Sub-Total of Non-Current Assets |
6,274,927,824.46 |
| Total Assets |
11,454,821,170.32 |
| Short-Term Loans |
2,444,162,480.31 |
| Trading Financial liabilities |
-- |
| Notes Payable |
103,767,075.82 |
| Accounts Payable |
1,302,408,893.86 |
| Accounts Received In Advance |
1,478,507.58 |
| Employee Compensation Payable |
38,823,760.69 |
| Taxes Payable |
40,229,410.82 |
| Interest Payable |
-- |
| Dividend Payable |
35,741,819.49 |
| Other payables |
76,797,113.84 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
967,458,220.00 |
| Other Current Liabilities |
116,106,902.76 |
| Sub-Total of Current Liabilities |
6,105,277,720.85 |
| Long-term Loans |
609,217,104.63 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
82,581,596.15 |
| Special Payable |
-- |
| Estimatied Liabilities |
47,106,027.84 |
| Deferred Income Tax Liabilities |
25,732,417.58 |
| Other Non-Current Liabilities |
64,200,339.67 |
| Sub-Total of Non-Current Liabilities |
898,970,841.45 |
| Total Liabilities |
7,004,248,562.30 |
| Paid-In Capital(Or Share Stock) |
2,716,377,683.00 |
| Capital Surplus |
2,621,272,863.36 |
| Surplus Reserve |
49,656,991.83 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,067,357,477.60 |
| Minority Stockholder's Interest |
105,400,514.67 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,345,172,093.35 |
| Owner's Equity（Stockholder's Equity） |
4,450,572,608.02 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,454,821,170.32 |
